I recently spoke with Michael May, President and Chief Executive Officer of CCRM, a Canadian not-for-profit that develops technologies and launches new companies by supporting both academic and industry activities in the field of regenerative medicine, including cell and gene therapy. Our conversation focused on the intersection of medical devices in Regenerative Medicine. Brian Hanrahan: It […]
The post Michael May discusses the intersection of medical devices in regenerative medicine appeared first on StarFish Medical.